how long can you take retatrutide Promises Big Weight Loss, but Safety Remains a Question Retatrutide, a new weight loss

And the molecule at the center of that bet is amycretin

Delivering a hormone-based medication through intact skin is one of the most difficult challenges in pharmaceutical science, especially when the molecule involved is large and water-soluble

It is especially relevant for patients with overweight or obesity who also have high blood pressure, high cholesterol, elevated blood sugar, insulin resistance, fatty liver risk, sleep apnea, a family history of heart disease, or prior cardiovascular disease

Clinical trials have demonstrated weight loss ranging from approximately 10% with GLP-1 agents at weight management doses (e.g., semaglutide 2.4 mg in the STEP trials) to over 20% with tirzepatide at higher doses (SURMOUNT trials)